EUVIMEDEUVIMED entdecken
Leserbrief

Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply

M F W Gee iD, E B De Vol iD, H R Levy iD, A T Boltyenkov iD, Sanyal Aj iD

Alimentary Pharmacology & Therapeutics · 03.11.2026

DOI: 10.1111/apt.71077 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Alimentary Pharmacology & Therapeutics, online erschienen am 03.11.2026. Verfasst von M F W Gee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Siemens Healthineers, Tarrytown, New York, USA. Die Arbeit nennt 9 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Siemens Healthineers, Tarrytown, New York, USA.
  • Temerty Faculty of Medicine, Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Division of Gastroenterology, Hepatology and Nutrition, Stravitz-Sanyal Institute for Liver Disease and Metabolic Health, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.

ORCID-Profile: M F W Gee, E B De Vol, H R Levy, A T Boltyenkov, Sanyal Aj

Zitieren

APA

Gee, M. F. W., De Vol, E. B., Levy, H. R., Boltyenkov, A. T., & Aj, S. (2026). Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.71077

Vancouver

Gee MFW, De Vol EB, Levy HR, Boltyenkov AT, Aj S. Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026. doi:10.1111/apt.71077

BibTeX
@article{Gee2026,
  author = {Gee, M F W and De Vol, E B and Levy, H R and Boltyenkov, A T and Aj, Sanyal},
  title = {Letter: Interpreting Rule‐Out and Rule‐In Enhanced Liver Fibrosis Thresholds in Metabolic Dysfunction‐Associated Steatotic Liver Disease. Authors' Reply},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  doi = {10.1111/apt.71077}
}
Kostenlos starten →